Similar articles

• Binding of cyclic nucleotides with proteins in malignant and adenosine cyclic 3':5'-monophosphate-induced "differentiated" neuroblastoma cells in culture.

  Prasad KN, Sinha PK, Sahu SK, Brown JL. Prasad KN, et al. Cancer Res. 1976 Jul;36(7 PT 1):2290-6. Cancer Res. 1976. PMID: 179701
• Cyclic AMP and cyclic GMP content and binding in malignancy.

  Goldberg ML, Burke GC, Morris HP. Goldberg ML, et al. Biochem Biophys Res Commun. 1975 Jan 20;62(2):320-7. doi: 10.1016/s0006-291x(75)80141-0. Biochem Biophys Res Commun. 1975. PMID: 163087 No abstract available.
• Phosphorylation of chromosomal and ribosomal proteins and intracellular levels of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during amino acid starvation in Landschutz tumour cells.

  Jolicoeur P, Lemay A, Labrie F, Steiner AL. Jolicoeur P, et al. Exp Cell Res. 1974 Dec;89(2):231-40. doi: 10.1016/0014-4827(74)90786-1. Exp Cell Res. 1974. PMID: 4376086 No abstract available.
• The chemistry and biological properties of nucleotides related to nucleoside 3',5'-cyclic phosphates.

  Simon LN, Shuman DA, Robins RK. Simon LN, et al. Adv Cyclic Nucleotide Res. 1973;3:225-353. Adv Cyclic Nucleotide Res. 1973. PMID: 4357644 Review. No abstract available.
• On the role of cyclic nucleotides in tumor of human nervous tissue: an overview.

  Frattola L, Cerri C, Villani R, Trabucchi M. Frattola L, et al. J Neurosurg Sci. 1979 Oct-Dec;23(4):257-63. J Neurosurg Sci. 1979. PMID: 44883 Review. No abstract available.